What is the primary driver of revenue growth for Axon Enterprise?

Revenue growth is driven by strong performance in both the TASER Weapons segment, particularly with upgrades to newer models like the X26P, and the rapidly expanding AXON segment, which includes body cameras and the EVIDENCE.com cloud-based evidence management system. The AXON segment is showing particularly high growth rates, indicating increasing adoption of their technology solutions by law enforcement.

How has the company's profitability changed?

Profitability has significantly improved. Net income more than doubled year-over-year, driven by a substantial increase in net sales, improved gross margins (up to 66.7%), and efficient management of operating expenses. The shift towards higher-margin AXON products and services is also contributing positively to profitability.

What is the company's financial health and liquidity position?

Axon Enterprise maintains a strong financial position. As of March 31, 2015, the company had $104.8 million in cash, cash equivalents, and investments. They have a revolving line of credit of $10.0 million available, with no outstanding borrowings. The company reported positive operating cash flow and has a healthy balance sheet with minimal long-term debt.

Are there any significant legal or regulatory risks impacting the company?

The company is involved in product litigation, primarily related to the use of its TASER Conducted Electrical Weapons (CEWs). While they have implemented risk management strategies to reduce litigation exposure, the outcome of these cases remains uncertain. The company also notes potential impacts from changes in tax laws and is subject to tax examinations. However, management believes that, as of March 31, 2015, these legal matters will not materially affect the company's financial condition or results of operations, though this cannot be guaranteed.

AXON 10-Q Quarterly Report Q1 FY2015 — Revenue, Net Income, EPS

Summary

Axon Enterprise, Inc. (formerly TASER International, Inc.) reported a strong first quarter for 2015, demonstrating significant top-line growth and improved profitability. Net sales increased by 23.7% year-over-year to $44.8 million, driven by robust performance in both its TASER Weapons segment (up 18.1%) and the rapidly growing AXON segment (up 73.1%). The AXON segment, encompassing cameras and EVIDENCE.com, showed particular strength with substantial increases in sales of AXON solutions and EVIDENCE.com subscriptions. The company also achieved a significant improvement in gross margins, rising to 66.7% from 61.4% in the prior year, attributed to increased sales leverage and improved efficiency. This, combined with a more favorable mix of sales towards higher-margin products and services, contributed to a substantial increase in net income, which more than doubled to $7.2 million, or $0.13 per diluted share, from $3.4 million, or $0.06 per diluted share, in the first quarter of 2014. The company's balance sheet remains healthy with a significant cash position and no significant debt.

Financial Highlights

49 data points

Beta

Revenue

$44.76M

0.7% Gross Margin

Net Income

$7.21M

0.2% Net Margin

EPS (Diluted)

$0.13

Total Assets

$195.81M

Cash & Equivalents

$46.85M

Free Cash Flow

$12.58M

Financial Statements

Beta

Revenue	$44.76M
Cost of Revenue	$14.89M
Gross Profit	$29.87M
R&D Expenses	$4.56M
SG&A Expenses	$14.56M
Operating Expenses	$19.12M
Operating Income	$10.74M
Net Income	$7.21M
EPS (Basic)	$0.14
EPS (Diluted)	$0.13
Shares Outstanding (Basic)	53.17M
Shares Outstanding (Diluted)	54.51M

Key Highlights

1Net sales increased by 23.7% to $44.8 million in Q1 2015 compared to Q1 2014.
2The AXON segment experienced rapid growth, with net sales increasing by 73.1% to $6.4 million.
3Gross margin improved significantly to 66.7% in Q1 2015 from 61.4% in Q1 2014, reflecting improved product mix and operational efficiencies.
4Net income more than doubled to $7.2 million ($0.13 per diluted share) in Q1 2015, up from $3.4 million ($0.06 per diluted share) in Q1 2014.
5Operating cash flow saw a substantial increase to $13.0 million in Q1 2015 from $4.3 million in Q1 2014.
6The company's cash, cash equivalents, and investments stood at $104.8 million as of March 31, 2015, indicating a strong liquidity position.
7Bookings for EVIDENCE.com and AXON products showed a significant increase to $22.9 million in Q1 2015, indicating strong future sales potential.

AXON ENTERPRISE, INC. Quarterly Report for Q1 Ended Mar 31, 2015

Summary

Financial Highlights

Key Highlights

Frequently Asked Questions